Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-13

FDA Approved: AVEED — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AVEED, a testosterone undecanoate product, submitted by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVEED (Testosterone undecanoate)

Snippet

SUPPL AP for AVEED (TESTOSTERONE UNDECANOATE)